Home » ARK THERAPEUTICS GETS 2.19 MLN EUR GRANT FOR NEW FINNISH MANUFACTURING FACILITY
ARK THERAPEUTICS GETS 2.19 MLN EUR GRANT FOR NEW FINNISH MANUFACTURING FACILITY
Ark Therapeutics Group PLC said it has received a 2.19 mln eur grant from the Employment and Economic Development Centre of Finland for its new GMP manufacturing facility. The facility is currently being prepared for commercial-scale manufacture of Cerepro, a gene-based medicine for the treatment of brain cancer. The new facility will significantly increase Ark's manufacturing capacity and scope in the gene-based medicines. Work on the facility has already commenced and Ark Therapeutics expects it to be operational for validation to commence towards the end of 2007.
Interactive Investor (http://www.iii.co.uk/news/?type=afxnews&articleid=5454190&subject=economic&action=article)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May